TrialBMC cancer2018

RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis.

Lin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.